Cayla-InvivoGen is a biotechnology company developing innovative products
based on breakthroughs in molecular and cell biology.
Created in 1977 by a university team, Cayla is specialized in the extraction
and purification of fermentation based products derived from a large variety of
microorganisms.
The American subsidiary, InvivoGen, was founded in 1998 to provide the
scientific community with innovative reagents for research in molecular and
cell biology.
Launched in 2007, InvivoGen Therapeutics is dedicated to the research,
development and manufacturing of gene therapy and immunotherapy products.
based on breakthroughs in molecular and cell biology.
Created in 1977 by a university team, Cayla is specialized in the extraction
and purification of fermentation based products derived from a large variety of
microorganisms.
The American subsidiary, InvivoGen, was founded in 1998 to provide the
scientific community with innovative reagents for research in molecular and
cell biology.
Launched in 2007, InvivoGen Therapeutics is dedicated to the research,
development and manufacturing of gene therapy and immunotherapy products.